Market Overview

Priority Review System for Drugs and Medical Devices in Japan

  There are various priority review systems to provide the necessary useful new drugs and medical devices to the market as quickly as possible. Following the US FDA's first track system, Japan’s first general priority review system was established in the 1990s. Since then, various new priority review systems, summarized below, have been established and applied.

1. Orphan drug priority review system
2. SAKIGAKE (Pioneer) Review Designation System
3. Conditional Early Approval System
4. Conditional and Time-limited Approval System for regenerative medicines
5. The general priority review system



A Series of Articles

About the Author

Related Articles

No information is found.

Digital Health
U.S. eHealth Journal

Vol. 81 (Issued at 2023/1/24)

ジャーナル81号のトピックは、Alex Therapeutics社(肺線維症患者向けDTx)、PatientsLikeMe(患者SNSコミュニティ)、LetsGetChecked社(在宅診断テスト)、Sonde Health社(音声バイオマーカー)、Eargo社(OTC補聴器) など

Most Popular


Online Roundtable Discussion Among Clinical Doctors 【Part 5】

LSMIP Editorial Office


Aevice Health Develops Wearable Stethoscopes for Chronic Respiratory Disease Patients

Kazunori Seto M.D.


Interview with Dental Start-up SQRIE - About Social Challenges and Services it Offers

Megumi Kamo DDS, PhD.


Mitsutoshi Yamada


MSA Partners, LLC

Press Room